Trial result

Eight Patients Cannot Solve Alzheimer’s. They Can Tell Us What the Next Trial Must Prove.

Deep learning uncovers a new ECG biomarker for sudden cardiac death

ADHD Does Not Stop Being ADHD When Anxiety Walks Into the Room

Huntington’s Needs More Than a Better Curve

For Drug-Resistant Epilepsy, Surgery Should Not Be the Only Door
Type 1 diabetes has a kidney problem. FDA is now fast-tracking a possible answer.

Gene therapy is entering cardiology. Friedreich ataxia shows why rare heart disease may be the first test

MASH, a serious fatty liver disease, is becoming a cardiometabolic condition

Cholesterol prevention is moving earlier. Is Europe ready to treat inherited risk before adulthood?
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
